News Briefs

Forbion leads $37m round for Oxular

Oxular, a retinal therapeutics development company, has raised $37 million in funding.

1 March 2021

Oxular, a retinal therapeutics development company, has raised $37 million in funding. Forbion led the round.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now